BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 38459540)

  • 1. Characterization of preclinical Alzheimer's disease model: spontaneous type 2 diabetic cynomolgus monkeys with systemic pro-inflammation, positive biomarkers and developing AD-like pathology.
    Huang X; Huang S; Fu F; Song J; Zhang Y; Yue F
    Alzheimers Res Ther; 2024 Mar; 16(1):52. PubMed ID: 38459540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type II Diabetes Mellitus Accelerates Age-Dependent Aβ Pathology in Cynomolgus Monkey Brain.
    Kimura N
    Adv Exp Med Biol; 2019; 1128():133-145. PubMed ID: 31062328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau pathology in aged cynomolgus monkeys is progressive supranuclear palsy/corticobasal degeneration- but not Alzheimer disease-like -Ultrastructural mapping of tau by EDX.
    Uchihara T; Endo K; Kondo H; Okabayashi S; Shimozawa N; Yasutomi Y; Adachi E; Kimura N
    Acta Neuropathol Commun; 2016 Nov; 4(1):118. PubMed ID: 27842611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus accelerates Aβ pathology in brain accompanied by enhanced GAβ generation in nonhuman primates.
    Okabayashi S; Shimozawa N; Yasutomi Y; Yanagisawa K; Kimura N
    PLoS One; 2015; 10(2):e0117362. PubMed ID: 25675436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological changes induced by Alzheimer's brain inoculation in amyloid-beta plaque-bearing mice.
    Lam S; Hérard AS; Boluda S; Petit F; Eddarkaoui S; Cambon K; ; Picq JL; Buée L; Duyckaerts C; Haïk S; Dhenain M
    Acta Neuropathol Commun; 2022 Aug; 10(1):112. PubMed ID: 35974399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating small extracellular vesicles in Alzheimer's disease: a case-control study of neuro-inflammation and synaptic dysfunction.
    Singh R; Rai S; Bharti PS; Zehra S; Gorai PK; Modi GP; Rani N; Dev K; Inampudi KK; Y VV; Chatterjee P; Nikolajeff F; Kumar S
    BMC Med; 2024 Jun; 22(1):254. PubMed ID: 38902659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
    Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
    Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-based Aβ42 increases in the earliest pre-pathological stage before decreasing with progressive amyloid pathology in preclinical models and human subjects: opening new avenues for prevention.
    Botella Lucena P; Vanherle S; Lodder C; Gutiérrez de Ravé M; Stancu IC; Lambrichts I; Vangheluwe R; Bruffaerts R; Dewachter I
    Acta Neuropathol; 2022 Sep; 144(3):489-508. PubMed ID: 35796870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.
    Ahmed ME; Iyer S; Thangavel R; Kempuraj D; Selvakumar GP; Raikwar SP; Zaheer S; Zaheer A
    J Alzheimers Dis; 2017; 60(3):1143-1160. PubMed ID: 28984607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer's Disease.
    Buchanan H; Mackay M; Palmer K; Tothová K; Katsur M; Platt B; Koss DJ
    Mol Neurobiol; 2020 Aug; 57(8):3258-3272. PubMed ID: 32514860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's Disease-Like Pathologies and Cognitive Impairments Induced by Formaldehyde in Non-Human Primates.
    Zhai R; Rizak J; Zheng N; He X; Li Z; Yin Y; Su T; He Y; He R; Ma Y; Yang M; Wang Z; Hu X
    Curr Alzheimer Res; 2018; 15(14):1304-1321. PubMed ID: 30182853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated inflammatory aging in Alzheimer's disease and its relation to amyloid, tau, and cognition.
    Cullen NC; Mälarstig AN; Stomrud E; Hansson O; Mattsson-Carlgren N
    Sci Rep; 2021 Jan; 11(1):1965. PubMed ID: 33479445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Levels of
    Piccarducci R; Pietrobono D; Pellegrini C; Daniele S; Fornai M; Antonioli L; Trincavelli ML; Blandizzi C; Martini C
    Oxid Med Cell Longev; 2019; 2019():5030475. PubMed ID: 31281579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorzoxazone exhibits neuroprotection against Alzheimer's disease by attenuating neuroinflammation and neurodegeneration in vitro and in vivo.
    Bai Y; Ma X
    Int Immunopharmacol; 2020 Nov; 88():106790. PubMed ID: 32795892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer's disease-like pathology?
    Kacířová M; Zmeškalová A; Kořínková L; Železná B; Kuneš J; Maletínská L
    Clin Sci (Lond); 2020 Mar; 134(5):547-570. PubMed ID: 32167154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.
    Scholtzova H; Chianchiano P; Pan J; Sun Y; Goñi F; Mehta PD; Wisniewski T
    Acta Neuropathol Commun; 2014 Sep; 2():101. PubMed ID: 25178404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial activation and inflammation along the Alzheimer's disease continuum.
    Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
    J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.